Externalizing and Attentional Behaviors in Children of Depressed Mothers Treated With a Selective Serotonin Reuptake Inhibitor Antidepressant During Pregnancy
Authors:
- Tim F. OberlanderTOTim F. Oberlander
- Pratibha ReebyePRPratibha Reebye
- Shaila MisriSMShaila Misri
- Michael PapsdorfMPMichael Papsdorf
- John KimJKJohn Kim
- Ruth E. GrunauRGRuth E. Grunau
Open Access
- 1 January 2007
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Pediatrics & Adolescent Medicine
- Vol. 161 (1) , 22-29
Abstract
Objective To evaluate attentional and activity behaviors in 4-year-olds following prenatal selective serotonin reuptake inhibitor (SSRI) exposure. Design Prospective cohort design. Setting Tertiary care center. Participants Twenty-two 4-year-olds with prolonged prenatal SSRI medication exposure and 14 children without prenatal exposure. Main Exposure Prenatal SSRI exposure. Main Outcome Measures Group differences in externalizing behaviors (according to the Child Behavior Checklist) and direct observations of child attention, activity, and impulsiveness in a laboratory setting using the procedure by Crowell and colleagues were compared, including measures of the duration of prenatal SSRI exposure, umbilical cord drug levels, a history of poor neonatal adaptation, and maternal mood. Results Externalizing behaviors did not differ between groups. Maternal depression and anxiety at the 4-year follow-up were associated with increased reports of externalizing behaviors. Increased externalizing behaviors were associated with increased umbilical cord drug levels (F1,34 = 6.3;P = .02), but when controlling for maternal depressed mood at the 4-year follow-up, such levels only accounted for 11.2% of the behavioral outcomes (P>.05). On direct observation, the persistence score for child behavior was significantly lower in the exposed group. Increased aggressiveness scores were associated with a history of poor neonatal adaptation, even when parental report of stress was added to the model (F1,34 = 4.0;P = .03); however, neither parental report of stress nor poor neonatal adaptation were significant (bothP = .09), suggesting that both are important, if not unique, predictors of child behavior. Conclusions These findings suggest that the best predictors of externalizing behaviors at age 4 years are current maternal mood and parental stress, regardless of prenatal depressed mood and SSRI treatment during pregnancy. It remains uncertain whether poor neonatal adaptation can be excluded as a possible predictor of externalizing behaviors.Keywords
This publication has 23 references indexed in Scilit:
- Neonatal Outcomes After Prenatal Exposure to Selective Serotonin Reuptake Inhibitor Antidepressants and Maternal Depression Using Population-Based Linked Health DataArchives of General Psychiatry, 2006
- Neonatal Signs After Late In Utero Exposure to Serotonin Reuptake Inhibitors: Literature Review and Implications for Clinical ApplicationsYearbook of Neonatal and Perinatal Medicine, 2006
- Pain Reactivity in 2-Month-Old Infants After Prenatal and Postnatal Selective Serotonin Reuptake Inhibitor Medication ExposurePediatrics, 2005
- Pharmacologic Factors Associated With Transient Neonatal Symptoms Following Prenatal Psychotropic Medication ExposureThe Journal of Clinical Psychiatry, 2004
- Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancyThe Journal of Pediatrics, 2003
- Antenatal Anxiety Predicts Child Behavioral/Emotional Problems Independently of Postnatal DepressionJournal of the American Academy of Child & Adolescent Psychiatry, 2002
- Child Development Following Exposure to Tricyclic Antidepressants or Fluoxetine Throughout Fetal Life: A Prospective, Controlled StudyAmerican Journal of Psychiatry, 2002
- Prolonged Prenatal Psychotropic Medication Exposure Alters Neonatal Acute Pain ResponsePediatric Research, 2002
- Cohort study of depressed mood during pregnancy and after childbirthBMJ, 2001
- Neurodevelopment of Children Exposed in Utero to Antidepressant DrugsNew England Journal of Medicine, 1997